АСКОРБІЛ ПАЛЬМІТАТ ПОСИЛЮЄ АНТИПРОЛІФЕРАТИВНИЙ ЕФЕКТ ТРАСТУЗУМАБУ ДЛЯ HER2-ПОЗИТИВНИХ КЛІТИН РАКУ ГРУДНОЇ ЗАЛОЗИ
Background. Breast cancer (BC) accounts for about 30% of cancers in women, with a mortality rate of around 15%. HER2- positive BC, an aggressive subtype, represents 15—20% of all BC cases. High-dose vitamin C has shown antitumor effects by increasing reactive oxygen species in cancer cells without s...
Saved in:
| Date: | 2025 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2025
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |